keyword
https://read.qxmd.com/read/38550407/granulomatous-amyloid-angiopathy-in-a-patient-with-persistent-headache
#21
Richa Tikaria, Maham A Khan, Howard Chang
Cerebral amyloid angiopathy (CAA) is a type of cerebrovascular disorder characterized by the accumulation of amyloid beta peptide within the walls of small to medium-sized blood vessels in the brain and leptomeninges. This can cause a variety of symptoms, depending on the location and extent of the deposits. Common presentations of amyloid angiopathy include cognitive decline, memory loss, headaches, vision changes, stroke-like symptoms, and seizures. In some cases, there may be no noticeable symptoms. A 78-year-old female was admitted for ongoing evaluation of a persistent headache after her primary care physician (PCP) ordered outpatient magnetic resonance imaging (MRI) that showed findings concerning metastatic tumors versus infectious processes...
February 2024: Curēus
https://read.qxmd.com/read/38545560/case-report-necrotizing-leukomyelitis-and-meningitis-in-a-pomeranian
#22
Koen M Santifort, Laurent Garosi, Erik A W S Weerts
A 2.5-year-old female entire Pomeranian dog was presented for acute paraparesis progressing within 2 days to paraplegia. General physical examination was unremarkable. Neurological examination showed paraplegia without nociception, a mass reflex upon testing perineal reflexes and withdrawal reflexes in the pelvic limbs and patellar hyperreflexia. Cutaneous trunci reflexes were absent caudal to the level of the 6th thoracic vertebra. Spinal hyperesthesia was present. Neuroanatomical localization was consistent with a T3-L3 myelopathy...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38524040/lumbar-subarachnoid-peritoneal-shunting-deteriorates-superficial-siderosis-associated-with-a-dural-defect
#23
Narutada Ando, Yusuke Nakazawa, Takeshi Miyata, Takenori Ogura, Wataru Shiraishi, Taketo Hatano
Superficial siderosis is a disease in which hemosiderin is deposited under the leptomeninges and subpial layers of hindbrain structures, e.g., the cerebellum, brainstem, and eighth cranial nerve. The main symptoms of superficial siderosis are cerebellar ataxia, hearing loss, cognitive decline, and myelopathy. The activities of daily living of patients with superficial siderosis are severely impaired due to the progressive symptoms. Here, we report a patient with superficial siderosis whose symptoms deteriorated after lumbar subarachnoid-peritoneal (L-P) shunt surgery...
February 2024: Curēus
https://read.qxmd.com/read/38513197/furmonertinib-and-intrathecal-pemetrexed-chemotherapy-rechallenges-osimertinib-refractory-leptomeningeal-metastasis-in-a-non-small-cell-lung-cancer-patient-harboring-egfr20-r776s-c797s-and-egfr21-l858r-compound-egfr-mutations-a-case-report
#24
JOURNAL ARTICLE
Guoxia Jia, Shoaib Bashir, Minting Ye, Yin Li, Mingyao Lai, Linbo Cai, Meng Xu
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are considered the first-line treatment for advanced or metastatic non-small cell lung cancer (NSCLC) patients harboring EGFR mutations. However, due to the rarity of cases, the response of EGFR-TKIs in patients harboring uncommon compound EGFR mutations still needs to be determined. Here, we demonstrated the case of a 47-year-old smoker diagnosed with leptomeningeal metastasis from NSCLC and had EGFR20 R776S, C797S, and EGFR21 L858R compound mutations...
March 15, 2024: Anti-cancer Drugs
https://read.qxmd.com/read/38506182/clinical-and-neuroimaging-phenotypes-of-autoimmune-glial-fibrillary-acidic-protein-astrocytopathy-a-systematic-review-and-meta-analysis
#25
REVIEW
Caroline Hagbohm, Russell Ouellette, Eoin P Flanagan, Dagur I Jonsson, Fredrik Piehl, Brenda Banwell, Ronny Wickström, Ellen Iacobaeus, Tobias Granberg, Benjamin V Ineichen
OBJECTIVE: This study was undertaken to provide a comprehensive review of neuroimaging characteristics and corresponding clinical phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A), a rare but severe neuroinflammatory disorder, to facilitate early diagnosis and appropriate treatment. METHODS: A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis)-conforming systematic review and meta-analysis was performed on all available data from January 2016 to June 2023...
March 20, 2024: European Journal of Neurology
https://read.qxmd.com/read/38501815/impact-of-cerebral-revascularization-on-pial-collateral-flow-in-patients-with-unilateral-moyamoya-disease-using-quantitative-magnetic-resonance-angiography
#26
JOURNAL ARTICLE
Brandon A Santhumayor, Timothy G White, Danielle Golub, Moses Rivera, Justin Turpin, David Golombeck, Brendan Ryu, Kevin Shah, Rafael Ortiz, Karen Black, Jeffrey M Katz, Amir R Dehdashti, David J Langer
BACKGROUND AND OBJECTIVES: Moyamoya disease (MMD) is a chronic steno-occlusive disease of the intracranial circulation that depends on neoangiogenesis of collateral vessels to maintain cerebral perfusion and is primarily managed with cerebral revascularization surgery. A quantitative assessment of preoperative and postoperative collateral flow using quantitative magnetic resonance angiography with noninvasive optimal vessel analysis (NOVA) was used to illustrate the impact of revascularization on cerebral flow distribution...
March 19, 2024: Neurosurgery
https://read.qxmd.com/read/38500181/molecular-and-clinicopathologic-characteristics-of-cns-embryonal-tumors-with-brd4-leutx-fusion
#27
JOURNAL ARTICLE
Felipe Andreiuolo, Christina K Ferrone, Sharika Rajan, Arie Perry, Ekin Guney, Elaine Cham, Caterina Giannini, Angus Toland, Nicholas Willard, Andrea Silveira de Souza, Karen Dazelle, Hye-Jung Chung, Omkar Singh, Kyle Conway, Nicholas Coley, Christopher Dampier, Zied Abdullaev, Drew Pratt, Patrick J Cimino, Martha Quezado, Kenneth Aldape
Central nervous system (CNS) embryonal tumors are a heterogeneous group of high-grade malignancies, and the increasing clinical use of methylation profiling and next-generation sequencing has led to the identification of molecularly distinct subtypes. One proposed tumor type, CNS tumor with BRD4::LEUTX fusion, has been described. As only a few CNS tumors with BRD4::LEUTX fusions have been described, we herein characterize a cohort of 9 such cases (4 new, 5 previously published) to further describe their clinicopathologic and molecular features...
March 18, 2024: Acta Neuropathologica Communications
https://read.qxmd.com/read/38488902/degro-guideline-for-personalized-radiotherapy-of-brain-metastases-and-leptomeningeal-carcinomatosis-in-patients-with-breast-cancer
#28
REVIEW
Kai J Borm, Sophie T Behzadi, Juliane Hörner-Rieber, David Krug, Rene Baumann, Stefanie Corradini, Marciana Nona Duma, Jürgen Dunst, Gerd Fastner, Petra Feyer, Rainer Fietkau, Wulf Haase, Wolfgang Harms, Thomas Hehr, Christiane Matuschek, Marc D Piroth, Leonard Christopher Schmeel, Rainer Souchon, Vratislav Strnad, Wilfried Budach, Stephanie E Combs
PURPOSE: The aim of this review was to evaluate the existing evidence for radiotherapy for brain metastases in breast cancer patients and provide recommendations for the use of radiotherapy for brain metastases and leptomeningeal carcinomatosis. MATERIALS AND METHODS: For the current review, a PubMed search was conducted including articles from 01/1985 to 05/2023. The search was performed using the following terms: (brain metastases OR leptomeningeal carcinomatosis) AND (breast cancer OR breast) AND (radiotherapy OR ablative radiotherapy OR radiosurgery OR stereotactic OR radiation)...
March 15, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38475765/pre-operative-vs-post-operative-stereotactic-radiosurgery-for-operative-metastatic-brain-tumors-study-protocol-for-a-phase-iii-clinical-trial
#29
JOURNAL ARTICLE
David M Routman, Ignacio Jusue-Torres, Paul D Brown, Daniel M Trifiletti, Sujay A Vora, Desmond A Brown, Ian F Parney, Terry C Burns, Elizabeth Yan
BACKGROUND AND OBJECTIVES: Almost one third of cancer patients in the United States will develop brain metastases on an annual basis. Surgical resection is indicated in the setting of brain metastases for reasons, such as maximizing local control in select patients, decompression of mass effect, and/or tissue diagnosis. The current standard of care following resection of a brain metastasis has shifted from whole brain radiation therapy to post-operative stereotactic radiosurgery (SRS)...
March 12, 2024: BMC Cancer
https://read.qxmd.com/read/38471800/an-autopsy-proven-case-based-review-of-autoimmune-encephalitis
#30
REVIEW
Yu-Mi Shim, Seong-Ik Kim, So Dug Lim, Kwanghoon Lee, Eric Eunshik Kim, Jae Kyung Won, Sung-Hye Park
Autoimmune encephalitis (AIE) is a type of immunoreactive encephalitic disorder and is recognized as the most prevalent noninfectious encephalitis. Nevertheless, the rarity of definitive AIE diagnosis through biopsy or autopsy represents a significant hurdle to understanding and managing the disease. In this article, we present the pathological findings of AIE and review the literature based on a distinct case of AIE presenting as CD8+ T-lymphocyte predominant encephalitis. We describe the clinical progression, diagnostic imaging, laboratory data, and autopsy findings of an 80-year-old deceased male patient...
February 29, 2024: Experimental Neurobiology
https://read.qxmd.com/read/38468819/a-teenage-girl-with-altered-mental-status-and-paraparesis
#31
Ryo Miyakawa, Janice Louie, Chris Keh, Lisa Chen, Babak Javid, Joel D Ernst, Neela Goswami, Felicia C Chow
A teenage girl presented with fever and altered mental status. MRI showed diffuse leptomeningeal enhancement of the brain and spine. She was diagnosed by a positive cerebrospinal fluid (CSF) culture with tuberculous (TB) meningitis and was started on anti-TB medications and corticosteroids. Her mental status improved, but she was noted to have proximal weakness of the lower extremities. In the course of tapering corticosteroids at week 11 of anti-TB therapy, she became acutely confused and febrile. MRI demonstrated interval development of tuberculomas in the brain and a mass lesion in the thoracic spine causing cord compression...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38464207/feasibility-of-safe-outpatient-treatment-in-pediatric-patients-following-intraventricular-radioimmunotherapy-with-131i-omburtamab-for-leptomeningeal-disease
#32
Kavya Prasad, Brian E Serencsits, Bae P Chu, Lawrence T Dauer, Maria Donzelli, Ellen Basu, Kim Kramer, Neeta Pandit-Taskar
Background Radiolabeled antibody 131 I-omburtamab was administered intraventricularly in patients with leptomeningeal disease under an institutionally approved study (# NCT03275402 ). Radiation safety precautions were tailored for individual patients, enabling outpatient treatment based on in-depth, evidence-based recommendations for such precautions. The imperative advancement of streamlined therapeutic administration procedures, eliminating the necessity for inpatient isolation and resource-intensive measures, holds pivotal significance...
February 28, 2024: Research Square
https://read.qxmd.com/read/38455772/concurrent-longitudinal-extensive-transverse-myelitis-and-leptomeningitis-in-west-nile-virus-a-report-of-a-rare-case
#33
Ivanna Joseph, Diamler Vadlamuri, Ivia E Rivera Agosto, Mehdi Ghasemi
Here we report a rare case with concurrent longitudinal extensive transverse myelitis (LETM) and leptomeningitis due to West Nile virus infection. A 47-year-old man initially presented with a six-day progressive, intermittent low-grade fever, headache, diplopia, malaise, myalgia, lower back pain, and difficulty walking that developed into progressive asymmetric paralysis. Initial lab work was notable for mild lactic acidosis and hyperCKemia. Brain MRI with contrast demonstrated small foci of leptomeningeal enhancement in the cerebellum, pons, medulla, and right CN VI at the cisternal segment...
February 2024: Curēus
https://read.qxmd.com/read/38455636/palliative-radiotherapy-for-leptomeningeal-metastases-after-photon-based-intensity-modulated-radiotherapy-in-a-nasopharyngeal-cancer-patient
#34
JOURNAL ARTICLE
Yoke S Marlina, Rima Novirianthy, Anđelija Beočanin
Leptomeningeal metastasis is a rare in nasopharyngeal carcinoma, affecting less than 5% of patients with a poor prognosis. The aim of this case report was to present management of palliative radiotherapy in leptomeningeal metastasis of nasopharyngeal carcinoma patient. A 33-year-old female presented with nasopharyngeal carcinoma with stage III, T3N3M0, WHO type III. The patient has received chemoradiation with photon-based intensity-modulated radiotherapy (IMRT) technique at the dose of 70 Gy in 33 fractions and showed a satisfactory outcome in 12 months follow-up...
December 2023: Narra J
https://read.qxmd.com/read/38450948/intracranial-invasion-of-a-mast-cell-tumour-in-a-dog-a-case-report-and-review-of-the-literature
#35
REVIEW
Edward Kingsbury, Petros Odatzoglou, A L Peschard, Hannah Wong, Richard Elders
An 11-year-old, female-neutered beagle was presented with a growing soft tissue mass arising within the deep tissues of the left cranial cervical region. At presentation, facial asymmetry was evident along with palpable lymphadenomegaly. Magnetic resonance imaging demonstrated a locally invasive cervical mass with intracranial invasion through focal osteolysis of the occipital bone. After antihistamine administration, cytology confirmed mast cell tumour (MCT) with metastasis to local lymph nodes and liver. The owner chose to pursue lomustine and prednisolone, which were dispensed, but, before home administration, prolonged seizures/status epilepticus occurred prompting euthanasia...
March 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38446375/correction-to-intrathecal-chemotherapy-for-leptomeningeal-disease-in-high-grade-gliomas-a-systematic-review
#36
Eric Singh, Muhammet Enes Gurses, Meredith C Costello, Chandler Berke, Victor M Lu, Lekhaj Daggubati, Ricardo J Komotar, Michael E Ivan, Ashish H Shah
No abstract text is available yet for this article.
March 6, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38445964/action-a-randomized-phase-3-study-of-onc201-dordaviprone-in-patients-with-newly-diagnosed-h3-k27m-mutant-diffuse-glioma
#37
JOURNAL ARTICLE
Isabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors, Martin van den Bent, Michael Vogelbaum, Joshua E Allen, Allen S Melemed, Rohinton S Tarapore, Patrick Y Wen, Timothy Cloughesy
BACKGROUND: H3 K27M-mutant diffuse glioma primarily affects children and young adults, is associated with a poor prognosis, and no effective systemic therapy is currently available. ONC201 (dordaviprone) has previously demonstrated efficacy in patients with recurrent disease. This phase 3 trial evaluates ONC201 in patients with newly diagnosed H3 K27M-mutant glioma. METHODS: ACTION (NCT05580562) is a randomized, double-blind, placebo-controlled, parallel-group, international Phase 3 study of ONC201 in newly diagnosed H3 K27M-mutant diffuse glioma...
March 6, 2024: Neuro-oncology
https://read.qxmd.com/read/38443012/igg4-related-neurological-disease-a-single-center-ambispective-study-from-south-india
#38
JOURNAL ARTICLE
Y Muralidhar Reddy, Subhendu Parida, Lalitha Pidaparthi, Shyam Kumar Jaiswal, Vijaya Tourani, Syed Osman, B Santosh Kumar, Jagarlapudi M K Murthy
IgG4-related disease (IgG4-RD) is an immune-mediated multi-system disorder. The nervous system (IgG4-RND) is rarely affected. We describe a short case series. We performed an ambispective analysis of IgG4-RND patients admitted at our centre between January 2016 and December 2022. Eight patients (M: F-2:6) were included with a mean age at presentation of 40.63 ± 17.88 years and disease duration of 5.16 ± 4.08 years. The common diseased sites were pachymeninges (7), orbits (4), paranasal sinuses (3), frontal lobe (1), hypophysis (1), leptomeninges (1), and middle ear (1)...
January 1, 2024: Neurology India
https://read.qxmd.com/read/38441840/prognostic-value-of-cerebrospinal-fluid-tumor-cell-count-in-leptomeningeal-disease-from-solid-tumors
#39
JOURNAL ARTICLE
Andrew B Barbour, Barbara Blouw, Lynne P Taylor, Jerome J Graber, Tresa McGranahan, Molly Blau, Lia M Halasz, Simon S Lo, Yolanda D Tseng, Vyshak Venur, Jonathan T Yang
PURPOSE: Treatment decisions for leptomeningeal disease (LMD) rely on patient risk stratification, since clinicians lack objective prognostic tools. The introduction of rare cell capture technology for identification of cerebrospinal fluid tumor cells (CSF-TCs), such as CNSide assay, improved the sensitivity of LMD diagnosis, but prognostic value is unknown. This study assesses the prognostic value of CSF-TC density in patients with LMD from solid tumors. METHODS: We conducted a retrospective cohort study of patients with newly diagnosed or previously treated LMD from a single institution who had CNSide assay testing for CSF-TCs from 2020 to 2023...
March 5, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38431371/grade-5-radiation-necrosis-after-whole-brain-radiation-therapy
#40
JOURNAL ARTICLE
Andrew Tam, Yun Rose Li, Terence Williams, Stephanie Yoon
Whole-brain radiation treatment is often considered for patients with leptomeningeal disease. There are limited reports of the development of radiation necrosis after whole-brain radiation treatment and fewer associating the presence of germline mutations with risk. We present a case report to highlight the need for consideration of radiosensitizing mutations when recommending radiation therapy.
2024: Practical Radiation Oncology
keyword
keyword
34259
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.